Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12Christopher Garris, Mikaël J. Pittet, Sean P. Arlauckas et al.|Immunity|2018Cited by 937
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responsesFelix Bayerl, Jan P. Böttcher, Chris D. Hermann et al.|Immunity|2023Cited by 176
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapyMarcel P. Trefny, Alfred Zippelius|Nature Communications|2023Cited by 88